Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Cancer Informatics
|
February 3, 2022
Chronotherapy of Early Colon Cancer: Advantage of Morning Dose Schedules
David E Axelrod
Cancer Chemotherapy and Pharmacology
|
September 13, 2019
A reliable method to determine which candidate chemotherapeutic drugs effectively inhibit tumor growth in patient-derived xenografts (PDX) in single mouse trials
Derek Gordon, David E Axelrod
Journal of Theoretical Biology
|
November 9, 2004
Evaluation of pathways for progression of heterogeneous breast tumors
Laura Sontag, David E Axelrod
Theoretical Biology & Medical Modelling
|
November 20, 2013
A calibrated agent-based computer model of stochastic cell dynamics in normal human colon crypts useful for in silico experiments
Rafael Bravo, David E Axelrod
Cancer Research Communications
|
January 23, 2023
Combination Chemotherapy of Multidrug-resistant Early-stage Colon Cancer: Determining Optimal Dose Schedules by High-performance Computer Simulation
Chase Cockrell, David E Axelrod
Cancer Informatics
|
January 25, 2019
Optimization of Dose Schedules for Chemotherapy of Early Colon Cancer Determined by High-Performance Computer Simulations
Chase Cockrell, David E Axelrod
Cancer Chemotherapy and Pharmacology
|
March 27, 2017
Effective chemotherapy of heterogeneous and drug-resistant early colon cancers by intermittent dose schedules: a computer simulation study
David E Axelrod, Sudeepti Vedula, James Obaniyi
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 10, 2005
About-weekly variations in nocturia
Germaine Cornélissen, David E Axelrod, Franz Halberg
JCO Clinical Cancer Informatics
|
June 9, 2020
Prevention of Colon Cancer Recurrence From Minimal Residual Disease: Computer Optimized Dose Schedules of Intermittent Apoptotic Adjuvant Therapy
Chase Cockrell, Joseph Teague, David E Axelrod
Plos One
|
June 18, 2025
Improved drug-screening tests of candidate anti-cancer drugs in patient-derived xenografts through use of numerous measures of tumor growth determined in multiple independent laboratories
Elizabeth Rosenzweig, David E Axelrod, Derek Gordon
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Cancer Informatics
|
February 3, 2022
Chronotherapy of Early Colon Cancer: Advantage of Morning Dose Schedules
David E Axelrod
Cancer Chemotherapy and Pharmacology
|
September 13, 2019
A reliable method to determine which candidate chemotherapeutic drugs effectively inhibit tumor growth in patient-derived xenografts (PDX) in single mouse trials
Derek Gordon, David E Axelrod
Journal of Theoretical Biology
|
November 9, 2004
Evaluation of pathways for progression of heterogeneous breast tumors
Laura Sontag, David E Axelrod
Theoretical Biology & Medical Modelling
|
November 20, 2013
A calibrated agent-based computer model of stochastic cell dynamics in normal human colon crypts useful for in silico experiments
Rafael Bravo, David E Axelrod
Cancer Research Communications
|
January 23, 2023
Combination Chemotherapy of Multidrug-resistant Early-stage Colon Cancer: Determining Optimal Dose Schedules by High-performance Computer Simulation
Chase Cockrell, David E Axelrod
Cancer Informatics
|
January 25, 2019
Optimization of Dose Schedules for Chemotherapy of Early Colon Cancer Determined by High-Performance Computer Simulations
Chase Cockrell, David E Axelrod
Cancer Chemotherapy and Pharmacology
|
March 27, 2017
Effective chemotherapy of heterogeneous and drug-resistant early colon cancers by intermittent dose schedules: a computer simulation study
David E Axelrod, Sudeepti Vedula, James Obaniyi
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 10, 2005
About-weekly variations in nocturia
Germaine Cornélissen, David E Axelrod, Franz Halberg
JCO Clinical Cancer Informatics
|
June 9, 2020
Prevention of Colon Cancer Recurrence From Minimal Residual Disease: Computer Optimized Dose Schedules of Intermittent Apoptotic Adjuvant Therapy
Chase Cockrell, Joseph Teague, David E Axelrod
Plos One
|
June 18, 2025
Improved drug-screening tests of candidate anti-cancer drugs in patient-derived xenografts through use of numerous measures of tumor growth determined in multiple independent laboratories
Elizabeth Rosenzweig, David E Axelrod, Derek Gordon
Page
of 2